Literature DB >> 11948565

Ethical framework for observational studies of medicinal drug exposure in pregnancy.

Gideon Koren1.   

Abstract

BACKGROUND: The conduct of human research in the teratogenicity of drugs, chemicals, radiation and infections is needed in order to close critical gaps in knowledge.
METHODS: We reviewed the various aspects of the ethics of conducting prospective human research in teratogenicity.
RESULTS: Such research should respect the confidentiality of pregnant women and their families. Because this research is observational, interpretation of results is difficult, and the study design should strive to meet the highest possible scientific standards attainable in the particular research conditions. It should also be acknowledged that confidentiality cannot be always adhered to (e.g., if the interview reveals risks to minors).
CONCLUSIONS: In general, the benefit risk ratio in this type of research is very favorable, although in specific cases the research follow-up may induce fears (e.g., drugs of abuse) in the woman being interviewed. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11948565     DOI: 10.1002/tera.10038

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  5 in total

1.  Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.

Authors:  Anders Engeland; Jørgen G Bramness; Anne Kjersti Daltveit; Marit Rønning; Svetlana Skurtveit; Kari Furu
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

2.  Prescribing in pregnancy and lactation.

Authors:  E J Begg
Journal:  Br J Clin Pharmacol       Date:  2008-05       Impact factor: 4.335

Review 3.  Ethics of studies of drugs in pregnancy.

Authors:  Doreen Matsui
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

4.  Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark.

Authors:  Anne-Mette Bay Bjørn; Mette Nørgaard; Heidi Holmager Hundborg; Ellen Aagaard Nohr; Vera Ehrenstein
Journal:  Clin Epidemiol       Date:  2011-05-02       Impact factor: 4.790

5.  Risk of childhood cerebral palsy following prenatal exposure to ß2-adrenergic receptor agonist: A nationwide cohort study.

Authors:  Lin Li; Ziliang Wang; Hong Liang; Fen Yang; Wei Yuan; Bizu Gelaye; Yongfu Yu; Maohua Miao; Mette Nørgaard; Jiong Li
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.